当前位置:首页 - 行情中心 - 爱博医疗(688050) - 财务分析 - 现金流量表

爱博医疗

(688050)

  

流通市值:76.58亿  总市值:76.58亿
流通股本:1.93亿   总股本:1.93亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金827,869,339.47303,215,161.061,502,945,814.471,108,625,964.68
  收到的税费返还4,061.52,210.44,489,101.291,898,371.88
  收到其他与经营活动有关的现金20,965,318.43,400,234.1652,156,386.7141,090,639.12
  经营活动现金流入小计848,838,719.37306,617,605.621,559,591,302.471,151,614,975.68
  购买商品、接受劳务支付的现金235,763,869.3893,636,572.24395,360,066.09309,184,916.83
  支付给职工以及为职工支付的现金213,338,209.14102,231,972.84382,549,003.68289,728,751.77
  支付的各项税费93,611,698.5535,544,165.08165,969,358.9128,613,296.73
  支付其他与经营活动有关的现金185,906,146.3756,500,460.19246,565,757.26193,991,479.34
  经营活动现金流出小计728,619,923.44287,913,170.351,190,444,185.93921,518,444.67
  经营活动产生的现金流量净额120,218,795.9318,704,435.27369,147,116.54230,096,531.01
二、投资活动产生的现金流量:
  收回投资收到的现金332,637,064.63187,600,0001,301,424,708.73991,244,708.73
  取得投资收益收到的现金859,381.07513,927.699,751,924.949,363,499.19
  处置固定资产、无形资产和其他长期资产收回的现金净额539,041.9306,408.9127,946.023,446.02
  处置子公司及其他营业单位收到的现金净额--2,300,152.862,300,152.86
  收到的其他与投资活动有关的现金31,261,979.541,225,962.36--
  投资活动现金流入小计365,297,467.14189,646,298.961,313,504,732.551,002,911,806.8
  购建固定资产、无形资产和其他长期资产支付的现金78,158,709.3331,424,584.87123,138,553.21100,069,357.26
  投资支付的现金224,100,40068,824,0001,304,000,000834,500,000
  取得子公司及其他营业单位支付的现金671,978,323.51665,974,539.7130,329,012.6130,029,012.61
  投资活动现金流出小计974,237,432.84766,223,124.581,457,467,565.82964,598,369.87
  投资活动产生的现金流量净额-608,939,965.7-576,576,825.62-143,962,833.2738,313,436.93
三、筹资活动产生的现金流量:
  吸收投资收到的现金762,739.2-287,710,182.36287,710,182.36
  取得借款收到的现金721,075,570.2651,423,553.435,000,00030,000,000
  收到其他与筹资活动有关的现金2,306,18095,402.694,810,416.634,279,269.52
  筹资活动现金流入小计724,144,489.4651,518,956.09327,520,598.99321,989,451.88
  偿还债务支付的现金158,561,320.6452,741,050.0957,765,13556,765,135
  分配股利、利润或偿付利息支付的现金75,734,067.974,862,919.6489,459,606.7583,002,252.99
  支付其他与筹资活动有关的现金26,168,518.77,743,249.77137,711,180.02133,138,142.51
  筹资活动现金流出小计260,463,907.3165,347,219.5284,935,921.77272,905,530.5
  筹资活动产生的现金流量净额463,680,582.09586,171,736.5942,584,677.2249,083,921.38
四、汇率变动对现金及现金等价物的影响-2,673,021.2-1,408,974.27-1,857,944.59-1,291,170.41
五、现金及现金等价物净增加额-27,713,608.8826,890,371.97265,911,015.9316,202,718.91
  加:期初现金及现金等价物余额629,809,494.46629,809,494.46363,898,478.56363,898,478.56
  期末现金及现金等价物余额602,095,885.58656,699,866.43629,809,494.46680,101,197.47
补充资料:
  净利润181,240,484.15-240,589,726.7-
  资产减值准备-834,526.75-87,418,079.48-
  固定资产和投资性房地产折旧70,707,984.15-143,146,000.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧70,707,984.15-143,146,000.31-
  无形资产摊销10,105,820.13-17,742,153.75-
  长期待摊费用摊销4,405,069.64-11,095,175.29-
  处置固定资产、无形资产和其他长期资产的损失-393,598.02-93,893.98-
  公允价值变动损失248,635.88--198,097.41-
  财务费用15,567,628.46-22,984,026.27-
  投资损失-1,393,255.34--4,616,821.32-
  递延所得税1,492,167.35--19,186,906.77-
  其中:递延所得税资产减少780,590.99--16,824,362.7-
    递延所得税负债增加711,576.36--2,362,544.07-
  存货的减少4,156,210.08--72,528,706.75-
  经营性应收项目的减少-58,576,474.4--129,385,771.9-
  经营性应付项目的增加-118,304,908-50,924,992.94-
  其他--2,024,941.82-
  现金的期末余额602,095,885.58-629,809,494.46-
  减:现金的期初余额629,809,494.46-363,898,478.56-
  现金及现金等价物的净增加额-27,713,608.88-265,911,015.9-
公告日期2026-08-262026-04-232026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑